https://www.selleckchem.com/products/uc2288.html
No differences were observed in IPSS (P=.6 or SHIM scores drop (P=.06) between groups. PSA drop seemed more pronounced in the TRUS only biopsy group compared to the 3DMB, but again without statistical significance (P=.06). Recurrence rate and BCF were lower in the 3DMB group (P .01). There was a higher rate of short-term complications detected in the TRUS only group (P=.02). BCF and local recurrence rates were lower among patients who underwent a confirmatory 3DMB before PCT, most likely due to better risk stratification in these p